Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
FDA advisers narrowly vote in favor of Sarepta's DMD gene therapy
Astellas' menopause drug scores FDA approval, after regulatory setback
New Eli Lilly-backed neurological disease biotech Nido unveils with $109M
*please scroll down for all the latest news*
